The liver is the second largest organ in the body. It can regrow itself and remove toxins from the blood.
A new blood test can identify which individuals of African ancestry carrying high-risk APOL1 gene variants are most likely to develop kidney failure, years before clinical disease becomes apparent.
This week, the FDA flexed its regulatory authority to approve the first medicine to treat focal segmental glomerulosclerosis, ...
A prespecified analysis of the NOAH-AFNET 6 trial investigated the impact of kidney function on cardiovascular outcome in ...
A new blood test can identify which individuals of African ancestry carrying high-risk APOL1 gene variants are most likely to ...
Researchers from Children's Hospital of Philadelphia (CHOP) developed a new RNA sequencing strategy that can reveal how ...
End-stage heart disease can leave patients breathless and fatigued despite treatment. Experts explain dilated cardiomyopathy, ...
An important finding from the study concerns a gene called APOL1. Two variants of the APOL1 gene, known as G1 and G2, ...
Metabolic liver disease (MASLD) could affect 1.8 billion people by 2050, driven by rising obesity and high blood sugar, a ...
Two studies presented at the American College of Cardiology Scientific Session offered insights into how to diagnose and ...
Parkinson’s disease (PD) is entering a pivotal phase. For decades, treatment has centred on dopamine replacement to manage ...
The liver is the second largest organ in the body. It can regrow itself and remove toxins from the blood.